AxxessBio is pleased to announce that TEPADINA® (thiotepa) 15mg, TEPADINA® (thiotepa) 100mg and TEPADINA® (thiotepa) 400mg multi chamber bag have been approved in Thailand with the following indications:
TEPADINA® is indicated, in combination with other chemotherapy medicinal products:
– With or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and paediatric patients
– When high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumours in adult and paediatric patients.
*Please refer to the local package insert for full prescribing information.
